Bioinformatics and Computational Biology in Drug Discovery and Development
Herausgeber: Loging, William T.
Bioinformatics and Computational Biology in Drug Discovery and Development
Herausgeber: Loging, William T.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
A comprehensive overview of the use of computational biology approaches in the drug discovery and development process.
Andere Kunden interessierten sich auch für
- Yun ZhengComputational Non-Coding RNA Biology161,99 €
- Viruti ShivanBioinformatics Scientist - The Comprehensive Guide30,99 €
- Berton ZbarFrom Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes44,99 €
- Shawn T. O'NeilA Primer for Computational Biology26,99 €
- Computational Chemistry Methodology in Structural Biology and Materials Sciences112,99 €
- Bioinformatics and Human Genomics Research93,99 €
- National Research CouncilBioinformatics54,99 €
-
-
-
A comprehensive overview of the use of computational biology approaches in the drug discovery and development process.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 254
- Erscheinungstermin: 21. März 2018
- Englisch
- Abmessung: 244mm x 170mm x 14mm
- Gewicht: 445g
- ISBN-13: 9781108461153
- ISBN-10: 1108461158
- Artikelnr.: 52152911
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
- Verlag: Cambridge University Press
- Seitenzahl: 254
- Erscheinungstermin: 21. März 2018
- Englisch
- Abmessung: 244mm x 170mm x 14mm
- Gewicht: 445g
- ISBN-13: 9781108461153
- ISBN-10: 1108461158
- Artikelnr.: 52152911
- Herstellerkennzeichnung
- Books on Demand GmbH
- In de Tarpen 42
- 22848 Norderstedt
- info@bod.de
- 040 53433511
Foreword; Preface: the future of drug discovery and health care Eric
Schadt; 1. The art and science of the Drug Discovery Pipeline (DDP) William
T. Loging; 2. Computational approaches to drug target identification Thomas
B. Freeman and Pek Lum; 3. Understanding human disease knowledge through
text mining Raul Rodriguez-Esteban; 4. Integrating translational biomarkers
into drug development Jonathan Phillips; 5. Computational phenotypic
assessment of small molecules in drug discovery William T. Loging and
Thomas B. Freeman; 6. Data visualization and the DDP process Ke Xu; 7.
Information visualization - important IT considerations Telmo Silva; 8. The
New Drug Application (NDA) and regulatory approval stages William T.
Loging, Marilyn Lewis, Bryn Williams-Jones and Roy Mansfield; 9. Clinical
trial failures and drug repositioning Mark Crawford and Jeff Handler;
Appendix I. Additional knowledge-based analysis approaches Raul
Rodriguez-Esteban; Appendix II. Open source tools and public data sources
Yirong Wang and William T. Loging; Index.
Schadt; 1. The art and science of the Drug Discovery Pipeline (DDP) William
T. Loging; 2. Computational approaches to drug target identification Thomas
B. Freeman and Pek Lum; 3. Understanding human disease knowledge through
text mining Raul Rodriguez-Esteban; 4. Integrating translational biomarkers
into drug development Jonathan Phillips; 5. Computational phenotypic
assessment of small molecules in drug discovery William T. Loging and
Thomas B. Freeman; 6. Data visualization and the DDP process Ke Xu; 7.
Information visualization - important IT considerations Telmo Silva; 8. The
New Drug Application (NDA) and regulatory approval stages William T.
Loging, Marilyn Lewis, Bryn Williams-Jones and Roy Mansfield; 9. Clinical
trial failures and drug repositioning Mark Crawford and Jeff Handler;
Appendix I. Additional knowledge-based analysis approaches Raul
Rodriguez-Esteban; Appendix II. Open source tools and public data sources
Yirong Wang and William T. Loging; Index.
Foreword; Preface: the future of drug discovery and health care Eric
Schadt; 1. The art and science of the Drug Discovery Pipeline (DDP) William
T. Loging; 2. Computational approaches to drug target identification Thomas
B. Freeman and Pek Lum; 3. Understanding human disease knowledge through
text mining Raul Rodriguez-Esteban; 4. Integrating translational biomarkers
into drug development Jonathan Phillips; 5. Computational phenotypic
assessment of small molecules in drug discovery William T. Loging and
Thomas B. Freeman; 6. Data visualization and the DDP process Ke Xu; 7.
Information visualization - important IT considerations Telmo Silva; 8. The
New Drug Application (NDA) and regulatory approval stages William T.
Loging, Marilyn Lewis, Bryn Williams-Jones and Roy Mansfield; 9. Clinical
trial failures and drug repositioning Mark Crawford and Jeff Handler;
Appendix I. Additional knowledge-based analysis approaches Raul
Rodriguez-Esteban; Appendix II. Open source tools and public data sources
Yirong Wang and William T. Loging; Index.
Schadt; 1. The art and science of the Drug Discovery Pipeline (DDP) William
T. Loging; 2. Computational approaches to drug target identification Thomas
B. Freeman and Pek Lum; 3. Understanding human disease knowledge through
text mining Raul Rodriguez-Esteban; 4. Integrating translational biomarkers
into drug development Jonathan Phillips; 5. Computational phenotypic
assessment of small molecules in drug discovery William T. Loging and
Thomas B. Freeman; 6. Data visualization and the DDP process Ke Xu; 7.
Information visualization - important IT considerations Telmo Silva; 8. The
New Drug Application (NDA) and regulatory approval stages William T.
Loging, Marilyn Lewis, Bryn Williams-Jones and Roy Mansfield; 9. Clinical
trial failures and drug repositioning Mark Crawford and Jeff Handler;
Appendix I. Additional knowledge-based analysis approaches Raul
Rodriguez-Esteban; Appendix II. Open source tools and public data sources
Yirong Wang and William T. Loging; Index.